(Q40390695)

English

Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

vector-borne disease

0 references

0 references

1 reference

based on heuristic

inferred from title

classical swine fever

1 reference

based on heuristic

inferred from title

classical swine fever virus

object named as

classical swine fever virus

1 reference

based on heuristic

inferred from title

author name string

He-Ping Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jian-Fu Sun

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Na Li

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yuan Sun

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yu Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hua-Ji Qiu

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

11 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Veterinary Immunology and Immunopathology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

131

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

158-166

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Novel marker vaccines against classical swine fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Helper T cell differentiation is controlled by the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Marker vaccine strategies and candidate CSFV marker vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Intercellular trafficking and protein delivery by a herpesvirus structural protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Diagnostic methods for detection of Classical swine fever virus--status quo and new developments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Combination DNA plus protein HIV vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Molecular characterization of pestiviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Lymphocyte proliferation response during Eimeria tenella infection assessed by a new, reliable, nonradioactive colorimetric assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Introduction to classical swine fever: virus, disease and control policy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

A genetic immunization adjuvant system based on BVP22-antigen fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Prime boost vaccines power up in people

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Vaccinology of classical swine fever: from lab to field

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.04.003

7 January 2021

Identifiers

10.1016/J.VETIMM.2009.04.003

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40390695&oldid=1896758531"